Literature DB >> 354677

Metronidazole (flagyl) and misonidazole (Ro-07-0582): reduction by facultative anaerobes and cytotoxic action on hypoxic bacteria and mammalian cells in vivo.

S H Basag, J R Dunlop, A J Searle, R L Willson.   

Abstract

The toxic actions of the "nitro" radiosensitizers, metronidazole and misonidazole on the bacteria E. coli B/r and Serratia marcescens have been investigated under anareobic and aerobic conditions. The rates of reduction of the drugs by suspensions of these bacteria as well as by suspensions microorganisms from the rat caecum have been measured. Both drugs were reduced or were toxic only under anaerobic conditions. In all instances misonidazole was reduced more rapidly than metronidazole but metronidazole was more toxic. It is suggested that these phenomena may model those occurring with hypoxic mammalian cells in vivo and that care should be taken before automatically extrapolating in vitro data to the in vivo situation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 354677      PMCID: PMC2149379     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


  4 in total

1.  Medium for the propagation and assay of lactic and other phages.

Authors:  J Douglas; A Qanber-Agha; V Phillips
Journal:  Lab Pract       Date:  1974-01

2.  Metronidazole (Flagyl): degradation by the intestinal flora.

Authors:  A J Searle; R L Willson
Journal:  Xenobiotica       Date:  1976-08       Impact factor: 1.908

3.  Effects of l-(2-nitro-l-imidazolyl)-3-methoxy-2-propanol and 2-methyl-5-nitroimidazole-l-ethanol against anaerobic and aerobic bacteria and protozoa.

Authors:  H N Prince; E Grunberg; E Titsworth; W F DeLorenzo
Journal:  Appl Microbiol       Date:  1969-11

4.  Metronidazole (Flagyl): characterization as a cytotoxic drug specific for hypoxic tumour cells.

Authors:  J L Foster; P J Conroy; A J Searle; R L Willson
Journal:  Br J Cancer       Date:  1976-05       Impact factor: 7.640

  4 in total
  1 in total

1.  Cytotoxicity of metronidazole (Flagyl) and misonidazole (Ro-07-0582): enhancement by lactate.

Authors:  J S Mahood; R L Willson
Journal:  Br J Cancer       Date:  1981-03       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.